Robinhood Plan 1 — Catalyst Cliff (Extended)

Account ••••7115 · Hard expiry 2026-12-31
Last update: 2026-07-16 08:10 PT (11:10 ET)
Market: OPEN · Agent: HEALTHY
Portfolio value
$6,347.40
Cost basis
$5,948.28
Unrealized + Realized P&L
+$399.12
Return
+6.71%

P&L history

Range:
Show:
First:
Peak:
Trough:
Current:
Change:

Positions

Symbol Shares Blended cost Current Day change Unrealized P&L %
VERA
Vera Therapeutics (atacicept, IgAN)
106 $39.26 $41.54 -2.26% +$241.68 +5.81%
VRDN
Viridian (Lumvoa, TED — approved) — EXITED 2026-07-16
0 $17.18 $18.31 +$105.74 (realized) +5.92%
Cash $1,944.16

Kill triggers (armed)

  • Combined -25% stop SAFE (+6.71% currently)
  • Gap-down >12% ARMED (VERA only; VRDN N/A, no position)
  • CRL VERA (post-approval) RESOLVED
  • CRL VRDN (post-approval) RESOLVED
  • New dilution ARMED
  • Insider panic-sell WINDOW CLOSED
  • Trailing stop (Rule 1) — VERA TRACKING (giveback 3.665% of 10%, no new peak)
  • Trailing stop (Rule 1) — VRDN FIRED 07-16 (sold 104sh @ $18.1973; re-entry permanently blocked, binary resolved)
  • Earnings miss + guide cut ARMED
  • Hard expiry 2026-12-31 SCHEDULED

Take-profit status

  • VERA +60% target: $62.82 (current $41.54 — need +51.2%)
  • VRDN — position exited 2026-07-16 via GM Rule-1 trailing stop before take-profit threshold reached (peak unrealized was +21.4% vs cost)
  • VERA approved ✓ — take-profit rule armed

Upcoming events

Recent activity (from trades.log)

Notes